BIOMAT Database Logo BIOMAT Database Logo

[The present status of drug therapy of Parkinson's syndrome]. 1962

K von MONAKOW

UI MeSH Term Description Entries
D010276 Parasympatholytics Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. Antispasmodic,Antispasmodic Agent,Antispasmodic Drug,Antispasmodics,Parasympathetic-Blocking Agent,Parasympathetic-Blocking Agents,Parasympatholytic,Parasympatholytic Agent,Parasympatholytic Drug,Spasmolytic,Spasmolytics,Antispasmodic Agents,Antispasmodic Drugs,Antispasmodic Effect,Antispasmodic Effects,Parasympatholytic Agents,Parasympatholytic Drugs,Parasympatholytic Effect,Parasympatholytic Effects,Agent, Antispasmodic,Agent, Parasympathetic-Blocking,Agent, Parasympatholytic,Agents, Antispasmodic,Agents, Parasympathetic-Blocking,Agents, Parasympatholytic,Drug, Antispasmodic,Drug, Parasympatholytic,Drugs, Antispasmodic,Drugs, Parasympatholytic,Effect, Antispasmodic,Effect, Parasympatholytic,Effects, Antispasmodic,Effects, Parasympatholytic,Parasympathetic Blocking Agent,Parasympathetic Blocking Agents
D010300 Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

K von MONAKOW
[The present status of echinococcosis drug therapy].
August 1980, Therapie der Gegenwart,
K von MONAKOW
[THE PRESENT STATUS OF ANTIHYPERTENSIVE DRUG THERAPY].
October 1964, Munchener medizinische Wochenschrift (1950),
K von MONAKOW
The drug therapy of Parkinson's syndrome.
March 1954, The Medical clinics of North America,
K von MONAKOW
[Present status of non-drug therapy and transcranial magnetic stimulation therapy for patients with Parkinson's disease].
August 2003, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
K von MONAKOW
Advances in drug development for Parkinson's disease: present status.
January 2014, Pharmacology,
K von MONAKOW
[Present status of drug therapy of depression].
July 1968, Nihon rinsho. Japanese journal of clinical medicine,
K von MONAKOW
[Present status of drug therapy of hypertension].
July 1962, Praxis,
K von MONAKOW
[Present status of drug therapy in arrhythmia].
March 1995, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
K von MONAKOW
The status of present-day drug therapy of hypertension.
January 1956, American practitioner and digest of treatment,
K von MONAKOW
[The present status of drug therapy of rheumatoid arthritis].
June 1984, Casopis lekaru ceskych,
Copied contents to your clipboard!